CANY
KIN

Caxton Associates (New York)’s Kindred Biosciences, Inc. KIN Stock Holding History

Caxton Associates (New York)’s Portfolio KIN Stock Details KIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-11,713
Closed -$107K – 624
2021
Q2 		$107K Buy
+11,713
New +$107K 0.01% 424